Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model

Published: April 30, 2023

Abstract

Source: Ramirez-Moya, J. et al. In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice. J. Vis. Exp. (2019)

This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1. Flank Inoculation of Cells and Intratumoral antagomiR Treatment Cell preparation Engineer a Cal62 human thyroid cancer cell line (KRASG12R and p53A161D mutations) to overexpress a transgenic construct that constitutively expresses GFP and luciferase (CMV-Firefly Luc-IRES-eGFP). Select the transgenic cells by…

Divulgaciones

The authors have nothing to disclose.

Materials

Basement Membrane Matrix: Matrigel Basement Membrane Matrix High Concentration Corning #354248
AntagomiR: mirVana miRNA inhibitor Thermo Fisher 4464088 In vivo ready
In vivo delivery reagent: Invivofectamine 3.0 Reagent Thermo Fisher IVF 3005
Negative control: mirVana miRNA Inhibitor, Negative Control #1 Thermo Fisher 4464077 In vivo ready
XenoLight D-Luciferin – K+ Salt Bioluminescent Substrate PerkinElmer 122799 Diluted in PBS
In vivo imaging software: IVISLumina II Imaging System Caliper Life Sciences

Tags

Play Video

Citar este artículo
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model. J. Vis. Exp. (Pending Publication), e20479, doi: (2023).

View Video